# OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study)

> **NCT06781944** · PHASE3 · RECRUITING · sponsor: **Huashan Hospital** · enrollment: 144 (estimated)

## Conditions studied

- Primary Membranous Nephropathy

## Interventions

- **DRUG:** Obinutuzumab
- **DRUG:** CTX combined with Glucocorticoids

## Key facts

- **NCT ID:** NCT06781944
- **Lead sponsor:** Huashan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-23
- **Primary completion:** 2028-05-31
- **Final completion:** 2028-05-31
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06781944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06781944, "OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study)". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06781944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*